To include your compound in the COVID-19 Resource Center, submit it here.

Dupilumab: Phase IIa data

Top-line data from a double-blind, international Phase IIa trial in 60 patients with moderate to severe chronic sinusitis with nasal polyps who did not respond to intranasal corticosteroids showed

Read the full 295 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE